D-576-2013 Class III Terminated

Recalled by Novartis Consumer Health — Lincoln, NE

FDA drug recall D-576-2013 was initiated by Novartis Consumer Health on Feb 19, 2013 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot. The recall status is terminated (terminated Nov 26, 2014). Affected quantity: 41,400 Boxes.

Recall details

Product Type
Drugs
Report Date
Jun 12, 2013
Initiation Date
Feb 19, 2013
Termination Date
Nov 26, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
41,400 Boxes

Product description

Lamisil AT Cream (terbinafine hydrochloride 1% antifungal), 12 gm ( .42 oz) Tubes and 30 gm (1 oz) Tubes packaged in one box, Novartis Consumer Health, Inc., Parsitan, NJ. UPC code: 300676249438. (Club Pack), NDC 0067-6295-43

Reason for recall

Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.

Distribution pattern

Nationwide and Puerto Rico, and Panama. Military distribution made.

Code information

Lot #: 10109590, 10111050, Exp 2/28/13.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-576-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-576-2013. Report a data issue: hello@regdatalab.com.